These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15475084)

  • 21. Searching for less toxic larynx preservation: a need for common definitions and metrics.
    Forastiere AA; Trotti AM
    J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
    [No Abstract]   [Full Text] [Related]  

  • 22. Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary.
    Lefebvre JL; Ang KK;
    Head Neck; 2009 Apr; 31(4):429-41. PubMed ID: 19283793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis: concurrent chemoradiotherapy and adjuvant chemotherapy for T2N0 glottic squamous cell carcinoma.
    Nonoshita T; Shioyama Y; Kunitake N; Nakamura K; Nomoto S; Ohga S; Toriya Y; Ono M; Honda H
    Fukuoka Igaku Zasshi; 2009 Jan; 100(1):26-31. PubMed ID: 19378773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of treatment on survival in patients with advanced laryngeal carcinoma.
    Gourin CG; Conger BT; Sheils WC; Bilodeau PA; Coleman TA; Porubsky ES
    Laryngoscope; 2009 Jul; 119(7):1312-7. PubMed ID: 19444887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent chemoradiotherapy with carboplatin and uracil-ftegafur in patients with stage two (T2 N0 M0) squamous cell carcinoma of the glottic larynx.
    Taguchi T; Tsukuda M; Mikami Y; Horiuchi C; Ishitoya JI; Katori H
    J Laryngol Otol; 2006 Jun; 120(6):478-81. PubMed ID: 16563197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
    Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
    J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Squamous cell carcinoma of the subglottis.
    Garas J; McGuirt WF
    Am J Otolaryngol; 2006; 27(1):1-4. PubMed ID: 16360814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunochemotherapy in cases of advanced laryngeal cancer].
    Singer Z; Kuśnierczyk W; Swierczyński Z; Swierczyśka B; Namyslowski G; Wróbel M
    Pol Tyg Lek; 1981 Jan; 36(4):141-4. PubMed ID: 7291075
    [No Abstract]   [Full Text] [Related]  

  • 30. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node status cannot be ignored in survival analysis of laryngeal cancer.
    Chatni SS; Thankappan K
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):786; author reply 786-7. PubMed ID: 18645134
    [No Abstract]   [Full Text] [Related]  

  • 32. Multimodal treatment for head and neck cancer.
    Lango MN
    Surg Clin North Am; 2009 Feb; 89(1):43-52, viii. PubMed ID: 19186230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management dilemmas of invasive subglottic carcinoma.
    Smee RI; Williams JR; Bridger GP
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):751-6. PubMed ID: 18849154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Larynx preservation: a debate worth preserving.
    Haddad R
    J Clin Oncol; 2013 Sep; 31(25):3170. PubMed ID: 23897959
    [No Abstract]   [Full Text] [Related]  

  • 35. Angiosarcoma developing after curative induction chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the larynx.
    Gagnon PJ; Galderisi C; Page BR; Holland JM
    Head Neck; 2009 Jun; 31(6):829-32. PubMed ID: 18853452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Profile of the research on cancer stem cells and its application on laryngeal solid tumors].
    Chen H; Zhou L
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):78-80. PubMed ID: 19484997
    [No Abstract]   [Full Text] [Related]  

  • 37. [Remote results in therapy of patients with laryngeal neoplasms].
    Kravchenko AA; Kornianskiĭ GP; Kaparulina SN; Shkandybin AI
    Zh Ushn Nos Gorl Bolezn; 1971; 31(2):111-2. PubMed ID: 5097881
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of quality of life outcomes in laryngeal cancer patients following chemoradiation vs. total laryngectomy.
    LoTempio MM; Wang KH; Sadeghi A; Delacure MD; Juillard GF; Wang MB
    Otolaryngol Head Neck Surg; 2005 Jun; 132(6):948-53. PubMed ID: 15944570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of head and neck surgical oncology research--a review and critical appraisal of landmark studies.
    Higgins KM; Wang JR
    Head Neck; 2008 Dec; 30(12):1636-42. PubMed ID: 18642286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy alone for early-stage squamous cell carcinoma of the larynx and hypopharynx.
    Foote RL
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S31-6. PubMed ID: 17848288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.